Augmented production of soluble CD93 in patients with systemic sclerosis and clinical association with severity of skin sclerosis
British Journal of Dermatology, 05/14/2012
Yanaba K et al. – Serum soluble form of CD93 (sCD93) level is increased in patients with systemic sclerosis (SSc) and correlates with the severity and activity of skin sclerosis. CD93 may contribute to the development of skin fibrosis in SSc.